10-hour time-restricted eating for people with type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-arm pragmatic trial enrolling adults with type 2 diabetes from the University of Kentucky Barnstable Brown Diabetes Center. Participants will follow a 10-hour daily time-restricted eating schedule for 12 months with periodic clinic visits for monitoring, support, and data collection. The protocol excludes pregnant or breastfeeding people, those with diagnosed eating disorders or night-shift workers, and those taking medications that induce hypoglycemia. The study will track adherence, feasibility, and metabolic outcomes such as glycemic control and related health measures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of Type 2 Diabetes

Exclusion Criteria:

* Pregnant or breastfeeding
* Diagnosed eating disorder
* Night shift worker
* Taking drugs which induce hypoglycemia
* Unable or unwilling to participate in the time-restricted eating intervention

Where it's running

• University of Kentucky Barnstable Brown Diabetes Center
  Lexington, Kentucky, United States Recruiting

Study contacts

• Principal investigator: Matt Thomas, PhD — University of Kentucky
• Study coordinator: Matt Thomas, PhD
• Email: MattThomas@uky.edu
• Phone: 859-562-0642

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.